Myhr KM - Search Results

1

Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs.

Oturai AB, Ryder LP, Fredrikson S, Myhr KM, Celius EG, Harbo HF, Andersen O, Akesson E, Hillert J, Madsen HO, Nyland H, Spurkland A, Datta P, Svejgaard A, Sorensen PS. Oturai AB, et al. Among authors: myhr km. Mult Scler. 2004 Feb;10(1):5-8. doi: 10.1191/1352458504ms975oa. Mult Scler. 2004. PMID: 14760946

2

[Multiple sclerosis].

Nyland H, Myhr KM. Nyland H, et al. Among authors: myhr km. Tidsskr Nor Laegeforen. 1995 Jun 30;115(17):2072-7. Tidsskr Nor Laegeforen. 1995. PMID: 7544032 Free article. Review. Norwegian.

3

Absence of HTLV-1 related sequences in MS from high prevalence areas in western Norway.

Myhr KM, Frost P, Grønning M, Midgard R, Kalland KH, Helland DE, Nyland HI. Myhr KM, et al. Acta Neurol Scand. 1994 Jan;89(1):65-8. doi: 10.1111/j.1600-0404.1994.tb01634.x. Acta Neurol Scand. 1994. PMID: 8178631

4

Bladder, bowel and sexual dysfunction in patients with multiple sclerosis--a cohort study.

Bakke A, Myhr KM, Grønning M, Nyland H. Bakke A, et al. Among authors: myhr km. Scand J Urol Nephrol Suppl. 1996;179:61-6. Scand J Urol Nephrol Suppl. 1996. PMID: 8908666

5

Treatment of relapsing-remittent multiple sclerosis with recombinant human interferon-alfa-2a: design of a randomised, placebo-controlled, double blind trial in Norway.

Nyland H, Myhr KM, Lillås F, Smievoll AI, Riise T, Nortvedt M, Nilsen R. Nyland H, et al. Among authors: myhr km. Mult Scler. 1996 Jul;1(6):372-5. doi: 10.1177/135245859600100618. Mult Scler. 1996. PMID: 9345420 Clinical Trial.

6

Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway.

Myhr KM, Riise T, Barrett-Connor E, Myrmel H, Vedeler C, Grønning M, Kalvenes MB, Nyland H. Myhr KM, et al. J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):539-42. doi: 10.1136/jnnp.64.4.539. J Neurol Neurosurg Psychiatry. 1998. PMID: 9576551 Free PMC article.

7

Interferon-alpha2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Norwegian Study Group on Interferon-alpha in Multiple Sclerosis.

Myhr KM, Riise T, Green Lilleås FE, Beiske TG, Celius EG, Edland A, Jensen D, Larsen JP, Nilsen R, Nortvedt MW, Smievoll AI, Vedeler C, Nyland HI. Myhr KM, et al. Neurology. 1999 Mar 23;52(5):1049-56. doi: 10.1212/wnl.52.5.1049. Neurology. 1999. PMID: 10102427 Clinical Trial.

8

Immunoglobulin G Fc-receptor (FcgammaR) IIA and IIIB polymorphisms related to disability in MS.

Myhr KM, Raknes G, Nyland H, Vedeler C. Myhr KM, et al. Neurology. 1999 Jun 10;52(9):1771-6. doi: 10.1212/wnl.52.9.1771. Neurology. 1999. PMID: 10371522

9

Quality of life in multiple sclerosis: measuring the disease effects more broadly.

Nortvedt MW, Riise T, Myhr KM, Nyland HI. Nortvedt MW, et al. Among authors: myhr km. Neurology. 1999 Sep 22;53(5):1098-103. doi: 10.1212/wnl.53.5.1098. Neurology. 1999. PMID: 10496273

10

Type I interferons and the quality of life of multiple sclerosis patients. Results from a clinical trial on interferon alfa-2a.

Nortvedt MW, Riise T, Myhr KM, Nyland HI, Hanestad BR. Nortvedt MW, et al. Among authors: myhr km. Mult Scler. 1999 Oct;5(5):317-22. doi: 10.1177/135245859900500503. Mult Scler. 1999. PMID: 10516774 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters